BAL 0.04% $12.88 bellamy's australia limited

Clearly out of favor, page-106

  1. 1,346 Posts.
    lightbulb Created with Sketch. 142

    Shorters are banking on these things:


    1. Slowing birthrates;

    2. Increased competition;

    3. No SAMR granted to BAL; and

    4. Increased Chinese Regulatory hurdles.

    However I believe that:


    1. BAL growth is following Organic growth trends worldwide for healthy eating and replacing mass produced food;

    2. Sufficient brand distinguisgment from other organic brands and local brands;

    3. SAMR will be granted + they own a CFDA facility unlike their competitors;

    4. I don't buy the Chinese regulatory boogie man. This is the 4th time analysts have brought out this issue over the last couple of years and Aussie companies are still competing.

    Last edited by Sentrypetal: 08/11/18
 
watchlist Created with Sketch. Add BAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.